• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma.

作者信息

McNally Michelle A, Vangipuram Ramya, Campbell Matthew T, Nagarajan Priyadharsini, Patel Anisha B, Curry Jonathan L, Heberton Meghan

机构信息

John P. and Katherine G. McGovern Medical School, Houston, Texas.

Department of Dermatology, John P. and Kathrine G. McGovern Medical School, Houston, Texas.

出版信息

JAAD Case Rep. 2021 Feb 23;10:82-84. doi: 10.1016/j.jdcr.2021.02.012. eCollection 2021 Apr.

DOI:10.1016/j.jdcr.2021.02.012
PMID:33778141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7985268/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/b8dbd6b148a8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/45d7517bf617/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/520550537809/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/d3e1bb98c25b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/b16b310fe062/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/b8dbd6b148a8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/45d7517bf617/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/520550537809/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/d3e1bb98c25b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/b16b310fe062/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb6/7985268/b8dbd6b148a8/gr5.jpg

相似文献

1
Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma.帕博利珠单抗治疗尿路上皮癌患者时出现的副肿瘤性天疱疮。
JAAD Case Rep. 2021 Feb 23;10:82-84. doi: 10.1016/j.jdcr.2021.02.012. eCollection 2021 Apr.
2
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.抗程序性死亡-1派姆单抗治疗并发化脓性汗腺炎的皮肤鳞状细胞癌引发的副肿瘤性天疱疮
Front Med (Lausanne). 2019 Nov 5;6:249. doi: 10.3389/fmed.2019.00249. eCollection 2019.
3
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.与检查点抑制剂治疗相关的基底层上方棘层松解性皮肤毒性：从副肿瘤性天疱疮样到格罗弗样病变的一系列免疫反应。
J Cutan Pathol. 2018 Oct;45(10):764-773. doi: 10.1111/cup.13312. Epub 2018 Jul 24.
4
Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event.帕博利珠单抗诱导的垂体炎伴孤立性促肾上腺皮质激素（ACTH）缺乏：一种罕见的免疫介导的不良事件。
Cureus. 2021 Jun 5;13(6):e15465. doi: 10.7759/cureus.15465.
5
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma.免疫相关不良反应与帕博利珠单抗治疗晚期尿路上皮癌疗效的相关性。
Oncology. 2020;98(4):237-242. doi: 10.1159/000505340. Epub 2020 Jan 14.
6
Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials.并非所有免疫检查点抑制剂都一样：癌症试验中免疫相关不良事件的荟萃分析和系统评价。
Crit Rev Oncol Hematol. 2017 Nov;119:1-12. doi: 10.1016/j.critrevonc.2017.09.002. Epub 2017 Sep 8.
7
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.免疫检查点抑制导致的罕见但严重的不良反应——孤立性中性粒细胞减少症。
J Immunother Cancer. 2019 Jul 5;7(1):169. doi: 10.1186/s40425-019-0648-3.
8
A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.帕博利珠单抗治疗转移性上尿路尿路上皮癌诱发肌炎后发生心肌炎致死一例
Int Heart J. 2020 Sep 29;61(5):1070-1074. doi: 10.1536/ihj.20-162. Epub 2020 Sep 12.
9
Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.晚期非小细胞肺癌患者中抗 PD-1 和抗 PD-L1 抗体免疫检查点抑制剂再挑战时的给药切换：病例系列和文献复习。
Thorac Cancer. 2020 Jul;11(7):1927-1933. doi: 10.1111/1759-7714.13483. Epub 2020 May 18.
10
Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis.帕博利珠单抗治疗转移性尿路上皮癌且不加重重症肌无力。
eNeurologicalSci. 2020 Mar 14;19:100236. doi: 10.1016/j.ensci.2020.100236. eCollection 2020 Jun.

引用本文的文献

1
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.接受免疫治疗的癌症患者中的自身免疫性大疱性皮肤病：文献综述及意大利多中心经验
Front Med (Lausanne). 2023 Jul 20;10:1208418. doi: 10.3389/fmed.2023.1208418. eCollection 2023.
2
Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies.现代靶向治疗和免疫治疗对皮肤恶性肿瘤患者的皮肤副作用
Cancers (Basel). 2023 Jun 9;15(12):3126. doi: 10.3390/cancers15123126.
3
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.

本文引用的文献

1
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.抗程序性死亡-1派姆单抗治疗并发化脓性汗腺炎的皮肤鳞状细胞癌引发的副肿瘤性天疱疮
Front Med (Lausanne). 2019 Nov 5;6:249. doi: 10.3389/fmed.2019.00249. eCollection 2019.
2
Atypical pemphigus developed in a patient with urothelial carcinoma treated with nivolumab.一名接受纳武单抗治疗的尿路上皮癌患者发生了非典型天疱疮。
J Dermatol. 2019 Mar;46(3):e90-e92. doi: 10.1111/1346-8138.14601. Epub 2018 Aug 31.
3
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.
新型靶向治疗药物的皮肤不良反应——免疫检查点抑制剂和 EGFR 抑制剂。
J Dtsch Dermatol Ges. 2021 Nov;19(11):1621-1643. doi: 10.1111/ddg.14641.
与检查点抑制剂治疗相关的基底层上方棘层松解性皮肤毒性：从副肿瘤性天疱疮样到格罗弗样病变的一系列免疫反应。
J Cutan Pathol. 2018 Oct;45(10):764-773. doi: 10.1111/cup.13312. Epub 2018 Jul 24.
4
PD-1 inhibitor-associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation-Report of 4 cases.伴有偶发性基底上层棘层松解或水疱形成的程序性死亡受体1（PD-1）抑制剂相关苔藓样炎症——4例报告
J Cutan Pathol. 2017 Oct;44(10):851-856. doi: 10.1111/cup.13013. Epub 2017 Aug 29.
5
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions.抗PD-1抗体疗法免疫检查点阻断引起的自身免疫性皮肤毒性：大疱性皮肤疹报告
J Cutan Pathol. 2016 Aug;43(8):688-96. doi: 10.1111/cup.12717. Epub 2016 May 8.
6
Paraneoplastic pemphigus without an underlying neoplasm.无潜在肿瘤的副肿瘤性天疱疮
Br J Dermatol. 2007 Mar;156(3):563-6. doi: 10.1111/j.1365-2133.2006.07605.x.
7
Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations.副肿瘤性天疱疮相关肿瘤：以非血液系统恶性肿瘤和口腔黏膜表现为重点的综述
Oral Oncol. 2004 Jul;40(6):553-62. doi: 10.1016/j.oraloncology.2003.09.020.
8
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation.自体骨髓移植后伴支气管上皮自身抗体沉积的副肿瘤性天疱疮
JAMA. 1992 Mar 18;267(11):1500-2.